Study: 1 in 10 Children with Cancer Improve in Phase 1 Drug Trials

February 28, 2018

(UPI) – One in 10 children with cancer saw their condition improve in Phase 1 clinical trials, and about 1 in 50 died from complications related to the drug, according to data research. Researchers examined 170 studies with 4,604 patients meeting eligibility criteria from January 2004 to March 2015, according to a study published this month in PLOS Medicine. “Little is known about the level of risk and benefit in pediatric Phase I trials in oncology,” researchers wrote.

Recommended Reading